February 15, 2017 / 6:12 PM / 8 months ago

Harvard, MIT research team holds on to gene-editing patent rights

Feb 15 (Reuters) - A team of researchers affiliated with the Massachusetts Institute of Technology and Harvard University will keep valuable patents on a revolutionary gene-editing technology known as CRISPR, a U.S. patent agency has ruled.

The U.S. Patent and Trademark Office’s Patent Trial and Appeal Board in Alexandria, Virginia on Wednesday dismissed a claim by a rival team, associated with the University of California at Berkeley and the University of Vienna in Austria, to have invented the technology first. (Reporting By Brendan Pierson in New York; Editing by Alan Crosby)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below